R&D | December 05, 2025
Industry-academia partnership key to advancing R&D agenda, says Dr. Jitendra Singh
Growing patent filings and tier-2 innovators reflect expanding national research base
Growing patent filings and tier-2 innovators reflect expanding national research base
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
LYMPHIR addresses a clear clinical need in a disease with limited treatment options
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
The trial tested six injectable doses and three oral doses over as long as 36 weeks
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Subscribe To Our Newsletter & Stay Updated
